Document Detail

The use of topical azelaic acid for common skin disorders other than inflammatory rosacea.
MedLine Citation:
PMID:  16566285     Owner:  NLM     Status:  MEDLINE    
Topical azelaic acid (AzA) is approved for the treatment of acne vulgaris and inflammatory (papulopustular) rosacea. Because of diverse mechanisms of action that correlate with potential therapeutic benefit, AzA has been used to treat several common dermatoses including acne vulgaris, inflammatory rosacea, erythematotelangiectatic rosacea, perioral dermatitis, melasma, and postinflammatory hyperpigmentation. This article reviews the therapeutic use of topical AzA for the treatment of common skin disorders other than the US Food and Drug Administration (FDA)-approved indications of acne vulgaris and inflammatory rosacea.
James Q Del Rosso
Related Documents :
9776475 - Anti-arthritic effects of the novel dipeptidyl peptidase iv inhibitors tmc-2a and tsl-225.
133645 - Analgesic and anti-inflammatory activity of 6-chloro-alpha-methyl-carbazole-2-acetic ac...
9557245 - Topical drug treatment in acne.
7080045 - Adolapin--a newly isolated analgetic and anti-inflammatory polypeptide from bee venom.
13886645 - The amino acid composition of human pituitary growth hormone.
21748285 - A tannic acid-based medical food, cesinex(®), exhibits broad-spectrum antidiarrheal pro...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Cutis     Volume:  77     ISSN:  0011-4162     ISO Abbreviation:  Cutis     Publication Date:  2006 Feb 
Date Detail:
Created Date:  2006-03-28     Completed Date:  2006-05-18     Revised Date:  2013-09-12    
Medline Journal Info:
Nlm Unique ID:  0006440     Medline TA:  Cutis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  22-4     Citation Subset:  IM    
University of Nevada School of Medicine, Las Vegas, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Cutaneous
Dermatitis, Perioral / drug therapy,  pathology
Dermatologic Agents / administration & dosage,  therapeutic use*
Dicarboxylic Acids / administration & dosage,  therapeutic use*
Melanosis / drug therapy,  pathology
Rosacea / drug therapy,  pathology
Skin Diseases / drug therapy*,  pathology
Reg. No./Substance:
0/Dermatologic Agents; 0/Dicarboxylic Acids; 123-99-9/azelaic acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A clinical overview of azelaic acid.
Next Document:  Viral and non-viral methods for gene transfer into skeletal muscle.